Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “ALKERMES PHARMA IRELAND LTD [IE]”

24 pharma patents match "ALKERMES PHARMA IRELAND LTD [IE]" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 24
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 24 pharmaceutical patents matching "ALKERMES PHARMA IRELAND LTD [IE]" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

24 results for “ALKERMES PHARMA IRELAND LTD [IE]” · 30,257 patents in full index Clear search

  1. AU 2022263543

    Pharmaceutical compositions comprising sorbitan esters

    ALKERMES PHARMA IRELAND LTD [IE] · Granted May 23, 2024 · Expires May 18, 2044

    granted
  2. US 2023302008

    METHODS OF ADMINISTERING INTRAVENOUS MELOXICAM IN A BOLUS DOSE

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Sep 28, 2023 · Expires Sep 23, 2043

    granted
  3. WO 2023156493

    FORMES CRISTALLINES DE NALTREXONE

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Aug 24, 2023 · Expires Aug 19, 2043

    granted
  4. WO 2023154894

    COMPOSITIONS ET PROCÉDÉS D'IMMUNOTHÉRAPIE ANTICANCÉREUSE

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Aug 17, 2023 · Expires Aug 12, 2043

    granted
  5. CY 2022006

    ΠΡΟΦΑΡΜΑΚΑ ΦΟΥΜΑΡΙΚΩΝ ΑΛΑΤΩΝ ΚΑΙ Η ΧΡΗΣΗ ΤΟΥΣ ΣΤΗΝ ΑΓΩΓΗ ΠΟΙΚΙΛΩΝ ΝΟΣΩΝ

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Jan 5, 2023 · Expires Dec 31, 2042

    granted
  6. US 2022354866

    IMMEDIATE RELEASE MULTILAYER TABLET

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Nov 10, 2022 · Expires Nov 5, 2042

    granted
  7. CA 3172871

    COMPOSITIONS DE POLYPEPTIDES DE FUSION D'IL-2 ET LEURS PROCEDES DE FABRICATION ET D'UTILISATION

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Nov 18, 2021 · Expires Nov 13, 2041

    granted
  8. CA 3172874

    COMPOSITIONS DE POLYPEPTIDES DE FUSION D'IL-2 ET LEURS PROCEDES DE FABRICATION ET D'UTILISATION

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Nov 18, 2021 · Expires Nov 13, 2041

    granted
  9. CA 3175356

    AGENTS IMMUNOSTIMULATEURS EN COMBINAISON AVEC DES INHIBITEURS DE L'ANGIOGENESE

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Oct 21, 2021 · Expires Oct 16, 2041

    granted
  10. CA 3175580

    AGENTS IMMUNOSTIMULATEURS EN COMBINAISON AVEC DES INHIBITEURS DE L'ANGIOGENESE

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Oct 21, 2021 · Expires Oct 16, 2041

    granted
  11. US 2021163596

    IMMUNOMODULATORY IL-2 AGENTS IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITORS

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Jun 3, 2021 · Expires May 29, 2041

    granted
  12. US 2021038684

    Compositions and Methods for Cancer Immunotherapy

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Feb 11, 2021 · Expires Feb 6, 2041

    granted
  13. WO 2020094634

    PROMÉDICAMENTS DE THIOPHÈNE DE NALTROXÈNE POUR COMPOSITIONS INJECTABLES À ACTION PROLONGÉE ET PROCÉDÉS ASSOCIÉS

    ALKERMES PHARMA IRELAND LTD [IE] · Granted May 14, 2020 · Expires May 9, 2040

    granted
  14. US 2020017529

    NOVEL THIENOTHIOPHENE COMPOUNDS FOR LONG-ACTING INJECTABLE COMPOSITIONS AND RELATED METHODS

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Jan 16, 2020 · Expires Jan 11, 2040

    granted
  15. US 2020016151

    NOVEL NAPHTHYLENYL COMPOUNDS FOR LONG-ACTING INJECTABLE COMPOSITIONS AND RELATED METHODS

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Jan 16, 2020 · Expires Jan 11, 2040

    granted
  16. US 2019298716

    Aripiprazole Dosing Strategy

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Oct 3, 2019 · Expires Sep 28, 2039

    granted
  17. HR P20190642

    ARIPIPRAZOLE PRODRUG COMPOSITIONS

    ALKERMES PHARMA IRELAND LTD [IE] · Granted May 31, 2019 · Expires May 26, 2039

    granted
  18. US 2017231981

    COMPOSITIONS OF MULTIPLE ARIPIPRAZOLE PRODRUGS

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Aug 17, 2017 · Expires Aug 12, 2037

    granted
  19. EP 3182958

    ARIPIPRAZOL-PRODRUGZUSAMMENSETZUNG

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Jun 28, 2017 · Expires Jun 23, 2037

    granted
  20. US 2017136004

    Opioid Agonist Antagonist Combinations

    ALKERMES PHARMA IRELAND LTD [IE] · Granted May 18, 2017 · Expires May 13, 2037

    granted
  21. US 2016228376

    MONOMETHYLFUMARATE PRODRUG COMPOSITIONS

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Aug 11, 2016 · Expires Aug 6, 2036

    granted
  22. US 2016051546

    CRYSTALLIZATION PROCESS OF ARIPIPRAZOLE DERIVATIVES IN EXTENDED RELEASE FORMULATIONS FOR TREATMENT OF SCHIZOPHRENIA

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Feb 25, 2016 · Expires Feb 20, 2036

    granted
  23. US 2016045495

    ARIPIPRAZOLE PRODRUG COMPOSITIONS

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Feb 18, 2016 · Expires Feb 13, 2036

    granted
  24. US 2015265529

    ARIPIPRAZOLE FORMULATIONS HAVING INCREASED INJECTION SPEEDS

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Sep 24, 2015 · Expires Sep 19, 2035

    granted